VGNX -- Variagenics, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VGNX -- Variagenics, Inc.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (254)	2/24/2003 1:14:57 PM
From: double-plus-good	Read Replies (2) of 269

"As previously announced, Nuvelo will take steps to help ensure that cash resulting from the merger will fund its operations through 2004. As of the merger date, January 31, 2003, Nuvelo had approximately $53.2 million cash available for the future operations." I am unclear if this figure accounts for the 10 million liability to Chairman Rathman. May have to wait for the conf. call this afternoon to clear that up. Pro forma balance sheet figures were not released so it is still unclear to me what the cash per share figure will ultimately be. ++

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next